Tumors with favorable ICI response, high density of IFN-γ producing CTLs, high tumor mutation burden or microsatellite instability (i.e., neoantigen production) can be categorized as “inflamed” TMEs with pre-existing immunity. Here, IFNG is linked to neoplasm.